Furthermore, levels of many of these biomarkers including AFP are elevated in the setting of steatosis and liver regeneration which can lead to a false positive diagnosis for HCC or not elevated in the setting of smaller tumors leading to a false negative diagnosis. The gene discussed is AFP; the disease is hepatocellular carcinoma.